Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 5, pp 1072–1077 | Cite as

Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic

  • Hua Cao
  • Jianmei Wu
  • Jinhua ZhangEmail author
Research Article

Abstract

Background In response to the recognized difficulty in the management of patients on anticoagulation therapy, anticoagulation management services were developed in both hospital anticoagulation clinics (HACs) and an online anticoagulation clinic (OAC) by a pharmacist. Objective To compare monitoring outcomes and complications of warfarin therapy managed by pharmacists via hospital or on-line. Setting The anticoagulation clinic of Fujian Medical University Union Hospital, China. Method A retrospective, observational cohort study was used to compare patients managed via hospital  to those managed o-line between December 2015 and 2016. The primary outcome was the percentage of time in the therapeutic range (TTR). The secondary outcomes were the incidence rates of hemorrhagic events, thrombotic events and extreme international normalized ratio (INR) values. Results A total of 152 patients were evaluated; 70 patients managed in a HAC were compared to 82 patients managed via an OAC. There were no significant differences in the TTR (78.9 vs. 74.0%, P = 0.393) and adverse events [major bleeding events (0 vs. 1.2%, P = 1.000), minor bleeding events (10.0 vs. 9.8%, P = 0.960), thromboembolic events (0 vs. 0%, P = 1.000), warfarin-related emergency visits (2.9 vs. 3.7%, P = 1.000)], warfarin-related hospital admissions (0 vs. 1.2%, P = 1.000), and the incidence of subtherapeutic (3.0 vs. 3.8%, P = 0.148), and extreme total (8.4 vs. 5.8%, P = 0.135), between the groups managed via HAC and OAC. Patients managed in the HAC were more stable on warfarin, with a higher percentage of INR values within the target therapeutic range (80.2 vs. 71.9%, P = 0.005) and a lower incidence of supratherapeutic INR values (8.4 vs. 18.5%, P = 0.001) compared to patients managed via OAC. Conclusion The management of oral anticoagulation therapy on-line yielded similar clinical outcomes compared to that achieved by management via the hospital, although the incidence of supra-therapeutic INR values was increased.

Keywords

Anticoagulants China International normalized ratio Pharmacists Telemedicine Warfarin 

Notes

Acknowledgements

We would like to thank Wang CH for helpful comments.

Funding

This research was funded by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [Grant Number: 2015B001]; the Fujian Medical Innovation Project [Grant Number: 2014-CX-18] and the Natural Science Foundation of Fujian Province of China [Grant Number: 2015Y0020].

Conflicts of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report. Chest. 2016;149(2):315–52.CrossRefGoogle Scholar
  2. 2.
    Downing A, Mortimer M, Hiers J. Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic international normalized ratios. Am J Health Syst Pharm. 2016;73:69–73.CrossRefGoogle Scholar
  3. 3.
    Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e152–84.  https://doi.org/10.2146/sp150039.CrossRefGoogle Scholar
  4. 4.
    Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother. 2008;42:777–82.CrossRefGoogle Scholar
  5. 5.
    Chau T, Rotbard M, King S, Li MM, Leong WA. Implementation and evaluation of a warfarin dosing service for rehabilitation medicine: report from a pilot project. Can J Hosp Pharm. 2006;59:136–47.Google Scholar
  6. 6.
    Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641–7.CrossRefGoogle Scholar
  7. 7.
    Wallvik J, Sjalander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25:123–8.CrossRefGoogle Scholar
  8. 8.
    Cryder BT, Felczak MA, Darkwa A, Patel H, Janociak JD, Rihani R. Transition of stable patients from traditional anticoagulation clinic services to telephonic management. Int J Clin Pharm. 2017;39:569–72.CrossRefGoogle Scholar
  9. 9.
    Lee JC, Horner KE, Krummel ML, McDanel DL. Clinical and financial outcomes evaluation of multimodal pharmacist warfarin management of a statewide urban and rural population. J Pharm Pract. 2018;31(2):150–6.CrossRefGoogle Scholar
  10. 10.
    Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service-results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015;13:14.CrossRefGoogle Scholar
  11. 11.
    McCahon D, Baker JM, Murray ET, Fitzmaurice DA. Assessing the utility of an online registry for patients monitoring their own warfarin therapy. J Clin Pathol. 2016;69:331–6.CrossRefGoogle Scholar
  12. 12.
    Wittkowsky AK, Nutescu EA, Blackburn J, Mullins J, Hardman J, Mitchell J, et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic settings. Chest. 2006;130:1385–9.CrossRefGoogle Scholar
  13. 13.
    Stoudenmire LG, DeRemer CE, Elewa H. Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes. Int J Hematol. 2014;100:119–24.CrossRefGoogle Scholar
  14. 14.
    Ryan F, Byrne S, O’Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an online consulting-based expert system. J Thromb Haemost. 2009;7:1284–90.CrossRefGoogle Scholar
  15. 15.
    Hassan S, Naboush A, Radbel J, Asaad R, Alkaied H, Demissie S, et al. Telephone-based anticoagulation management in the homebound setting: a retrospective observational study. Int J Gen Med. 2013;6:869–75.CrossRefGoogle Scholar
  16. 16.
    Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127:1515–22.CrossRefGoogle Scholar
  17. 17.
    Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62:601–9.CrossRefGoogle Scholar
  18. 18.
    Ahmed NO, Osman B, Abdelhai YM, El-Hadiyah TMH. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int J Clin Pharm. 2017;39(4):769–73.CrossRefGoogle Scholar
  19. 19.
    Faircloth JM, Miner KM, Alsaied T, Nelson N, Ciambarella J, Mizuno T, et al. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients. J Thromb Thrombolysis. 2017;44:38–47.CrossRefGoogle Scholar
  20. 20.
    Zhang J, Liu M, Chen Q, Wu J, Cao H. Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities. Thromb Res. 2017;157:136–8.CrossRefGoogle Scholar
  21. 21.
    Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62(5):601–9.CrossRefGoogle Scholar
  22. 22.
    You ZQ, Han XP, Lü L, Yeung CH. Empirical studies on the network of social groups: the case of tencent QQ. PLoS ONE. 2015;10(7):e0130538.  https://doi.org/10.1371/journal.pone.0130538.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.CrossRefGoogle Scholar
  24. 24.
    Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Thromb Haemost. 2005;3:692–4.CrossRefGoogle Scholar
  25. 25.
    Boman K, Davidson T, Gustavsson M, Olofsson M, Renström GB, Johansson L. Telemedicine improves the monitoring process in anticoagulant treatment. J Telemed Telecare. 2012;18:312–6.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Fujian Medical University Union HospitalFuzhouChina
  2. 2.Fujian Provincial Maternity And Child Health HospitalFuzhouChina

Personalised recommendations